Differential degradation of ferritin H- and L-chains: Accumulation of L-chain-rich ferritin in lens epithelial cells

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 10, 2005, Pages 3521-3529

  Goralska, Małgorzata ^a   Nagar, Steven ^a   Fletsher, Lloyd N ^a   McGahan, M Christine ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; LACTACYSTIN BETA LACTONE; APOFERRITIN; CYSTEINE PROTEINASE INHIBITOR; IRON; METHIONINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATARACT; CELL CULTURE; CELL INCLUSION; CONTROLLED STUDY; CYTOSOL; DOG; ENZYME LINKED IMMUNOSORBENT ASSAY; HEREDITARY HYPERFERRITINEMIA CATARACT SYNDROME; IMMUNOCYTOCHEMISTRY; IMMUNODETECTION; IRON STORAGE; LENS EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; AGING; ANIMAL; DRUG EFFECT; EPITHELIUM CELL; GENETIC TRANSFECTION; LENS; LYSOSOME; METABOLISM; PHYSIOLOGY; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS;

AGING; ANIMALS; APOFERRITINS; CELLS, CULTURED; CYSTEINE PROTEINASE INHIBITORS; DOGS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; FERRITINS; IRON; LENS, CRYSTALLINE; LYSOSOMES; METHIONINE; PLASMIDS; TRANSFECTION;

EID: 32944482461     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0358     Document Type: Article

References (33)

1. Rouault TA. Iron on the brain. Nat Genet. 2001;28:299-300.
2. Yefimova MG, Jeanny JC, Keller N, et al. Impaired retinal iron homeostasis associated with defective phagocytosis in Royal College of Surgeons rats. Invest Ophthalmol Vis Sci. 2002;43:537-545.
3. Sullivan JL. Iron and the sex difference in heart disease risk. Lancet. 1981;1:1293-1294.
4. Picard V, Epsztejn S, Santambrogio P, Cabantchik ZI, Beaumont C. Role of ferritin in the control of the labile iron pool in murine erythroleukemia cells. J Biol Chem. 1998;273:15382-15386.
5. Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta. 1996;1275:161-203.
6. Radisky DC, Kaplan J. Iron in cytosolic ferritin can be recycled through lysosomal degradation in human fibroblasts. Biochem J. 1998;336:201-205.
7. Roberts S, Bomford A. Ferritin iron kinetics and protein turnover in K562 cells. J Biol Chem. 1988;263:19181-19187.
8. Reinheckel T, Sitte N, Ullrich O, Kuckelkorn U, Davies KJ, Grune T. Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem J. 1998;335:637-642.
9. Shang F, Gong X, Palmer HJ, Nowell TR Jr, Taylor A. Age-related decline in ubiquitin conjugation in response to oxidative stress in the lens. Exp Eye Res. 1997;64:21-30.
10. Cuervo AM, Dice JF. How do intracellular proteolytic systems change with age? Front Biosci. 1998;3:D25-D43.
11. Wistow G, Bernstein SL, Wyatt MK, et al. Expressed sequence tag analysis of adult human lens for the NEIBank Project: over 2000 non-redundant transcripts, novel genes and splice variants. Mol Vis. 2002;8:171-184.
12. Hirose W, Ikematsu K, Tsuda R. Age-associated increases in heme oxygenase-1 and ferritin immunoreactivity in the autopsied brain. Leg Med (Tokyo). 2003;5(suppl 1):S360-S366.
13. Goralska M, Holley BL, McGahan MC. Identification of a mechanism by which lens epithelial cells limit accumulation of overexpressed ferritin H-chain. J Biol Chem. 2003;278:42920-42926.
14. Goralska M, Holley BL, McGahan MC. Overexpression of H- and L-ferritin subunits in lens epithelial cells: Fe metabolism and cellular response to UVB irradiation. Invest Ophthalmol Vis Sci. 2001;42:1721-1727.
15. Lee DH, Goldberg AL. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 1998;8:397-403.
16. Ciechanover A, Finley D, Varshavsky A. Ubiquitin dependence of selective protein degradation demonstrated in the mammalian cell cycle mutant ts85. Cell. 1984;37:57-66.
17. Rock KL, Gramm C, Rothstein L, et al. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 1994;78:761-771.
18. Craiu A, Gaczynska M, Akopian T, et al. Lactacystin and clastolactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation. J Biol Chem. 1997;272:13437-13445.
19. Shringarpure R, Grune T, Mehlhase J, Davies KJ. Ubiquitin conjugation is not required for the degradation of oxidized proteins by proteasome. J Biol Chem. 2003;278:311-318.
20. Kwok JC, Richardson DR, Children's Cancer Institute Australia for Medical Research IM, Chelation Program RSNSWA. Examination of the mechanism(s) involved in doxorubicin-mediated iron accumulation in ferritin: studies using metabolic inhibitors, protein synthesis inhibitors, and lysosomotropic agents. Mol Pharmacol. 2004;65:181-195.
21. Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ, Schreiber SL. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science. 1995;268:726-731.
22. Truty J, Malpe R, Linder MC. Iron prevents ferritin turnover in hepatic cells. J Biol Chem. 2001;276:48775-48780.
23. Kohgo Y, Yokota M, Drysdale JW. Differential turnover of rat liver isoferritins. J Biol Chem. 1980;255:5195-5200.
24. Miyazaki E, Kato J, Kobune M, et al. Denatured H-ferritin subunit is a major constituent of haemosiderin in the liver of patients with iron overload. Gut. 2002;50:413-419.
25. Vaisman B, Meyron-Holtz EG, Fibach E, Krichevsky AM, Konijn AM. Ferritin expression in maturing normal human erythroid precursors. Br J Haematol. 2000;110:394-401.
26. Girelli D, Corrocher R, Bisceglia L, et al. Molecular basis for the recently described hereditary hyperferritinemia-cataract syndrome: a mutation in the iron-responsive element of ferritin L-subunit gene (the "Verona mutation"). Blood. 1995;86:4050-4053.
27. Brooks DG, Manova-Todorova K, Farmer J, et al. Ferritin crystal cataracts in hereditary hyperferritinemia cataract syndrome. Invest Ophthalmol Vis Sci. 2002;43:1121-1126.
28. Hetet G, Devaux I, Soufir N, Grandchamp B, Beaumont C. Molecular analyses of patients with hyperferritinemia and normal serum iron values reveal both L ferritin IRE and 3 new ferroportin (slc11A3) mutations. Blood. 2003;102:1904-1910.
29. Grundke-Iqbal I, Fleming J, Tung YC, Lassmann H, Iqbal K, Joshi JG. Ferritin is a component of the neuritic (senile) plaque in Alzheimer dementia. Acta Neuropathol (Berl). 1990;81:105-110.
30. Curtis AR, Fey C, Morris CM, et al. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat Genet. 2001;28:350-354.
31. Vidal R, Ghetti B, Takao M, et al. Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. J Neuropathol Exp Neurol. 2004;63:363-380.
32. You SA, Archacki SR, Angheloiu G, et al. Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis. Physiol Genomics. 2003;13:25-30.
33. Taylor A, Berger JJ, Reddan J, Zuliani A. Effects of aging in vitro on intracellular proteolysis in cultured rabbit lens epithelial cells in the presence and absence of senim. In Vitro Cell Dev Biol. 1991;27A:287-292.